Neurocrine Biosciences
NBIX
#1536
Rank
$14.45 B
Marketcap
$142.25
Share price
-1.19%
Change (1 day)
-2.98%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no stock splits for this company